282 related articles for article (PubMed ID: 26743755)
1. A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.
Barth H; Crafoord S; Andréasson S; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):697-703. PubMed ID: 26743755
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model.
Barth H; Crafoord S; Arnér K; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):769-783. PubMed ID: 30656473
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment.
Schnichels S; Schneider N; Hohenadl C; Hurst J; Schatz A; Januschowski K; Spitzer MS
PLoS One; 2017; 12(3):e0172895. PubMed ID: 28248989
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits.
Pritchard CD; Crafoord S; Andréasson S; Arnér KM; O'Shea TM; Langer R; Ghosh FK
Acta Biomater; 2011 Mar; 7(3):936-43. PubMed ID: 21081184
[TBL] [Abstract][Full Text] [Related]
5. Experimental vitreous tamponade using polyalkylimide hydrogel.
Crafoord S; Andreasson S; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1167-74. PubMed ID: 21452039
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.
Hurst J; Rickmann A; Heider N; Hohenadl C; Reither C; Schatz A; Schnichels S; Januschowski K; Spitzer MS
Front Pharmacol; 2022; 13():817353. PubMed ID: 35308238
[No Abstract] [Full Text] [Related]
7. A New Retinal Detachment Treatment Model for Evaluation of Vitreous Tamponades.
Barth H; Crafoord S; Ghosh F
Curr Eye Res; 2021 Mar; 46(3):373-379. PubMed ID: 32806983
[No Abstract] [Full Text] [Related]
8. Retinal function after vitrectomy.
Wallentén KG; Andréasson S; Ghosh F
Retina; 2008 Apr; 28(4):558-63. PubMed ID: 18398357
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute.
Januschowski K; Schnichels S; Hurst J; Hohenadl C; Reither C; Rickmann A; Pohl L; Bartz-Schmidt KU; Spitzer MS
PLoS One; 2019; 14(1):e0209217. PubMed ID: 30615640
[TBL] [Abstract][Full Text] [Related]
10. The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute.
Schramm C; Spitzer MS; Henke-Fahle S; Steinmetz G; Januschowski K; Heiduschka P; Geis-Gerstorfer J; Biedermann T; Bartz-Schmidt KU; Szurman P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):613-21. PubMed ID: 22199245
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes.
Wang P; Gao Q; Jiang Z; Lin J; Liu Y; Chen J; Zhou L; Li H; Yang Q; Wang T
Clin Exp Ophthalmol; 2012; 40(1):e67-75. PubMed ID: 21883770
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility of polyvinyl alcohol/trisodium trimetaphosphate as vitreous substitute in experimental vitrectomy model in rabbits.
de Oliveira RA; Muralha FP; Grupenmacher AT; de Araújo Morandim-Giannetti A; Bersanetti PA; Maia M; Magalhães Junior O
J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):460-466. PubMed ID: 34328263
[TBL] [Abstract][Full Text] [Related]
13. A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve.
Gao Q; Mou S; Ge J; To CH; Hui Y; Liu A; Wang Z; Long C; Tan J
Eye (Lond); 2008 Mar; 22(3):461-8. PubMed ID: 17525767
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility and Efficacy of a Linearly Cross-Linked Sodium Hyaluronic Acid Hydrogel as a Retinal Patch in Rhegmatogenous Retinal Detachment Repairment.
Zheng C; Xi H; Wen D; Ke Y; Zhang X; Ren X; Li X
Front Bioeng Biotechnol; 2022; 10():914675. PubMed ID: 35860332
[TBL] [Abstract][Full Text] [Related]
15. Injectable self-crosslinking hydrogels based on hyaluronic acid as vitreous substitutes.
Yu S; Wang S; Xia L; Hu H; Zou M; Jiang Z; Chi J; Zhang Y; Li H; Yang C; Liu W; Han B
Int J Biol Macromol; 2022 May; 208():159-171. PubMed ID: 35301003
[TBL] [Abstract][Full Text] [Related]
16. [Early posterior capsule fibrosis after combined cataract and vitreoretinal surgery with intraocular air/SF6 gas tamponade].
Scharwey K; Pavlovic S; Jacobi KW
Klin Monbl Augenheilkd; 1998 Mar; 212(3):149-53. PubMed ID: 9592739
[TBL] [Abstract][Full Text] [Related]
17. Rabbit study of an in situ forming hydrogel vitreous substitute.
Swindle-Reilly KE; Shah M; Hamilton PD; Eskin TA; Kaushal S; Ravi N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4840-6. PubMed ID: 19324846
[TBL] [Abstract][Full Text] [Related]
18. Application of thermo-setting gel as artificial vitreous.
Katagiri Y; Iwasaki T; Ishikawa T; Yamakawa N; Suzuki H; Usui M
Jpn J Ophthalmol; 2005; 49(6):491-496. PubMed ID: 16365795
[TBL] [Abstract][Full Text] [Related]
19. A new model for in vitro testing of vitreous substitute candidates.
Barth H; Crafoord S; O'Shea TM; Pritchard CD; Langer R; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2014 Oct; 252(10):1581-92. PubMed ID: 25059475
[TBL] [Abstract][Full Text] [Related]
20. Intraocular use of hydrogel tissue adhesive in rabbit eyes.
Sueda J; Fukuchi T; Usumoto N; Okuno T; Arai M; Hirose T
Jpn J Ophthalmol; 2007; 51(2):89-95. PubMed ID: 17401616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
